opsona
Edit

opsona

http://www.opsona.com/
Last activity: 12.09.2016
Tags:DataDevelopmentDrugHumanMusicProductResearchTechnologyVideo
Opsona Therapeutics is a leading drug development company specialising in the human immune system. Opsona is identifying new ways to prevent and treat autoimmune/inflammatory conditions, cancers and infectious diseases. Opsona's drug discovery & development is focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signalling in human immunology. Since 2004, Opsona has also developed a unique and advanced pipeline of drugs. The company has research locations in Dublin (Ireland) and Lausanne (Switzerland).
Location: Ireland, Dublin City, Dublin
Member count: 11-50
Total raised: $47.287156M
Founded date: 2004

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
02.10.2013Series C$4.070473M-finsmes.co...
29.04.2013Series C$43.216683...-vcnewsdail...

Mentions in press and media 7

DateTitleDescriptionSource
12.09.2016Dublin Medical Startup Inflazome Raises €15mDublin startup Inflazome, which was formed in April of this year, has raised €15m to help it develop...businesspl...
09.01.2015Irish VC Fountain Healthcare launches $127.5M fund–Chrono Therapeutics, a Bay Area digital smoking cessation startup –Innocoll, an Irish maker of bio...medcitynew...
02.10.2013Opsona Adds 3M EURO To Series C Round DUBLIN, IRELAND, Opsona Therapeutics Limited, a drug development company, has added 3 million euro...vcnewsdail...
02.10.2013Opsona Therapeutics Raises €3M Series C Equity FinancingOpsona Therapeutics Limited, a Dublin, Ireland-based innate immune drug development company, raised ...finsmes.co...
29.04.2013Opsona Therapeutics $43M Series C DUBLIN, IRELAND, Innate immune drug development company, today announced that it has raised EURO33...vcnewsdail...
29.04.2013Opsona Therapeutics Raises €33M in Series C FinancingOpsona Therapeutics, a Dublin, Ireland-based developer of new treatments for inflammatory diseases, ...finsmes.co...
-Irish VC Fountain Healthcare launches $127.5M fundFountain Healthcare Partners just closed its second fund, with €85 million – or about $127.5 million...medcitynew...